We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 21-40 of 10,000 results
  1. The difference between dacomitinib and afatinib in effectiveness and safety in first-line treatment of patients with advanced EGFR-mutant non-small cell lung cancer: a real-world observational study

    Objectives

    The irreversible epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) afatinib and dacomitinib are approved for...

    Wen-Chien Cheng, Chi-Chien Lin, ... Te-Chun Hsia in BMC Cancer
    Article Open access 19 February 2024
  2. When to add anti-angiogenesis drugs to EGFR-mutated metastatic non–small cell lung cancer patients: a real-world study from Taiwan

    Background

    The addition of anti-angiogenesis drugs to epidermal growth factor receptor (EGFR)–tyrosine kinase inhibitor (TKI) or chemotherapy in...

    Chieh-Lung Chen, Sing-Ting Wang, ... Wen-Chien Cheng in BMC Cancer
    Article Open access 23 May 2022
  3. Modulation of chemoimmunotherapy efficacy in non-small cell lung cancer by sex and histology: a real-world, patient-level analysis

    Background

    It has been postulated that patient’s sex impacts response to immunotherapy. Sex modulation of immunotherapy benefit, however, has not yet...

    Stephanie Tuminello, Naomi Alpert, ... Emanuela Taioli in BMC Cancer
    Article Open access 19 January 2022
  4. A text-mining approach to study the real-world effectiveness and potentially fatal immune-related adverse events of PD-1 and PD-L1 inhibitors in older patients with stage III/IV non-small cell lung cancer

    Background

    This study was designed to investigate the impact of age on the effectiveness and immune-related adverse events (irAEs) of programmed...

    Hanieh Abedian Kalkhoran, Juliëtte Zwaveling, ... Loes E. Visser in BMC Cancer
    Article Open access 14 March 2023
  5. Factors associated with overall survival, progression-free survival and toxicity in patients with small cell lung cancer and thoracic irradiation in a clinical real-world setting

    Background

    Small-cell lung cancer (SCLC) is a malignant tumor known for its poor prognosis. In addition to chemotherapy and immunotherapy irradiation...

    Marie-Theres Kassik, Dirk Vordermark, ... Daniel Medenwald in Radiation Oncology
    Article Open access 18 April 2023
  6. Retrospective analysis of real-world treatment patterns and clinical outcomes in patients with advanced non-small cell lung cancer starting first-line systemic therapy in the United Kingdom

    Background

    The treatment landscape for advanced non-small cell lung cancer (aNSCLC) has evolved rapidly since immuno-oncology (IO) therapies were...

    Jason Lester, Carles Escriu, ... Vivek Pawar in BMC Cancer
    Article Open access 07 May 2021
  7. Real world practice of postoperative radiotherapy for patients with completely resected pIIIA-N2 non-small cell lung cancer: a national survey of radiation oncologists in China

    Background

    Results from Lung ART and PORT-C trials suggest that postoperative radiotherapy (PORT) cannot routinely be recommended as standard...

    Shujie Zhou, Yirui Zhai, ... Zhouguang Hui in Radiation Oncology
    Article Open access 25 January 2023
  8. Real world duration of curative intent breast, colorectal, non-small cell lung, and prostate cancer treatment

    Background

    Advances in curative treatment for breast, colorectal, NSCLC and prostate cancer have led to improvements in cancer survival. Cancer...

    Selina K. Wong, Jeremy Hamm, ... Cheryl Ho in BMC Cancer
    Article Open access 02 March 2021
  9. Efficacy and acquired resistance of EGFR-TKI combined with chemotherapy as first-line treatment for Chinese patients with advanced non-small cell lung cancer in a real-world setting

    Background

    To compare the benefits and explore the cause of acquired resistance of epidermal growth factor receptor tyrosine kinase inhibitor...

    Qianqian Wang, Wen Gao, ... Renhua Guo in BMC Cancer
    Article Open access 25 May 2021
  10. Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis

    Background

    The objective of this study was to describe the real-world treatment and overall survival (OS) of German patients with a diagnosis of...

    Fränce Hardtstock, David Myers, ... Frank Griesinger in BMC Cancer
    Article Open access 30 March 2020
  11. Characteristics and outcomes of patients with RET-fusion positive non-small lung cancer in real-world practice in the United States

    Background

    Contradictory and limited data are available about the presentation and outcomes of patients with RET -fusion positive metastatic NSCLC as...

    Lisa M. Hess, Yimei Han, ... Anthony Sireci in BMC Cancer
    Article Open access 05 January 2021
  12. Correction to: graph analysis of structural brain networks in Alzheimer’s disease: beyond small world properties

    The original version of the article contained an error in the electronic supplementary material. The caption of the figure in the electronic...

    Majnu John, Toshikazu Ikuta, Janina Ferbinteanu in Brain Structure and Function
    Article 26 September 2020
  13. Nomenclature report 2019: major histocompatibility complex genes and alleles of Great and Small Ape and Old and New World monkey species

    The major histocompatibility complex (MHC) is central to the innate and adaptive immune responses of jawed vertebrates. Characteristic of the MHC are...

    Natasja G. de Groot, Nel Otting, ... Ronald E. Bontrop in Immunogenetics
    Article 17 October 2019
  14. Altered functional brain networks in coronary heart disease: independent component analysis and graph theoretical analysis

    Coronary heart disease (CHD) confers a high risk of cognitive and mental impairments in patients. This study aimed to explore the association of CHD...

    Simin Lin, Puyeh Wu, ... Hengyu Zhao in Brain Structure and Function
    Article 09 November 2023
  15. Synchronization and oscillation behaviors of excitatory and inhibitory populations with spike-timing-dependent plasticity

    The effect of synaptic plasticity on the synchronization mechanism of the cerebral cortex has been a hot research topic over the past two decades....

    Yuan Wang, **a Shi, ... Junliang Chen in Cognitive Neurodynamics
    Article 02 August 2022
  16. Disrupted topological organization of functional brain networks in traumatic axonal injury

    Traumatic axonal injury (TAI) may result in the disruption of brain functional networks and is strongly associated with cognitive impairment....

    Jian Li, Yongqiang Shu, ... **anjun Zeng in Brain Imaging and Behavior
    Article Open access 04 December 2023
  17. Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer Programme

    The Cancer Programme of the 100,000 Genomes Project was an initiative to provide whole-genome sequencing (WGS) for patients with cancer, evaluating...

    Alona Sosinsky, John Ambrose, ... Nirupa Murugaesu in Nature Medicine
    Article Open access 11 January 2024
  18. Identification of a novel monopartite begomovirus associated with leaf curl disease of Citharexylum spinosum in India

    The present study reports the complete genome of a novel monopartite begomovirus, named tentatively as “Citharexylum leaf curl virus” (CitLCuV),...

    Damini Diksha, V. Kavi Sidharthan, V. K. Baranwal in Virus Genes
    Article 27 June 2024
  19. Electroencephalography-Derived Functional Connectivity in Sensorimotor Networks in Post Stroke Fatigue

    Background

    Poor suppression of anticipated sensory information from muscle contractions is thought to underlie high fatigue. Such diminished...

    Chi-Hsu Wu, William De Doncker, Annapoorna Kuppuswamy in Brain Topography
    Article Open access 17 June 2023
Did you find what you were looking for? Share feedback.